Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

V. Bossuyt; E. Provenzano; W. F. Symmans; J. C. Boughey; C. Coles; G. Curigliano; J. M. Dixon; L. J. Esserman; G. Fastner; T. Kuehn; F. Peintinger; G. Von Minckwitz; J. White; W. Yang; S. Badve; C. Denkert; G. Macgrogan; F. Penault-llorca; G. Viale; D. Cameron

doi:10.1093/annonc/mdv161

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

V. Bossuyt, E. Provenzano, W. F. Symmans, J. C. Boughey, C. Coles, G. Curigliano, J. M. Dixon, L. J. Esserman, G. Fastner, T. Kuehn, F. Peintinger, G. Von Minckwitz, J. White, W. Yang, S. Badve, C. Denkert, G. Macgrogan, F. Penault-llorca, G. Viale, D. Cameron

Research output: Contribution to journal › Literature review › peer-review

Original language	English
Pages (from-to)	1280-1291
Number of pages	12
Journal	Annals of Oncology
Volume	26
DOIs	https://doi.org/10.1093/annonc/mdv161
Publication status	Published - 27 May 2015

Access to Document

10.1093/annonc/mdv161

MANUSCRIPT-Bossuyt-AO-Mar 11 2015 with figures
This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Annals of Oncology following peer review. The definitive publisher-authenticated version, Ann Oncol (2015) 26 (7): 1280-1291. doi: 10.1093/annonc/mdv161 is available online at:http://annonc.oxfordjournals.org/content/26/7/1280
Accepted author manuscript, 736 KB

http://annonc.oxfordjournals.org/cgi/doi/10.1093/annonc/mdv161

Cite this

Bossuyt, V., Provenzano, E., Symmans, W. F., Boughey, J. C., Coles, C., Curigliano, G., Dixon, J. M., Esserman, L. J., Fastner, G., Kuehn, T., Peintinger, F., Von Minckwitz, G., White, J., Yang, W., Badve, S., Denkert, C., Macgrogan, G., Penault-llorca, F., Viale, G., & Cameron, D. (2015). Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Annals of Oncology, 26, 1280-1291. https://doi.org/10.1093/annonc/mdv161

@article{8b03cff7869844c987a2a89d220dc52c,

title = "Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration",

author = "V. Bossuyt and E. Provenzano and Symmans, {W. F.} and Boughey, {J. C.} and C. Coles and G. Curigliano and Dixon, {J. M.} and Esserman, {L. J.} and G. Fastner and T. Kuehn and F. Peintinger and {Von Minckwitz}, G. and J. White and W. Yang and S. Badve and C. Denkert and G. Macgrogan and F. Penault-llorca and G. Viale and D. Cameron",

year = "2015",

month = may,

day = "27",

doi = "10.1093/annonc/mdv161",

language = "English",

volume = "26",

pages = "1280--1291",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

}

Bossuyt, V, Provenzano, E, Symmans, WF, Boughey, JC, Coles, C, Curigliano, G, Dixon, JM, Esserman, LJ, Fastner, G, Kuehn, T, Peintinger, F, Von Minckwitz, G, White, J, Yang, W, Badve, S, Denkert, C, Macgrogan, G, Penault-llorca, F, Viale, G & Cameron, D 2015, 'Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration', Annals of Oncology, vol. 26, pp. 1280-1291. https://doi.org/10.1093/annonc/mdv161

TY - JOUR

T1 - Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

AU - Bossuyt, V.

AU - Provenzano, E.

AU - Symmans, W. F.

AU - Boughey, J. C.

AU - Coles, C.

AU - Curigliano, G.

AU - Dixon, J. M.

AU - Esserman, L. J.

AU - Fastner, G.

AU - Kuehn, T.

AU - Peintinger, F.

AU - Von Minckwitz, G.

AU - White, J.

AU - Yang, W.

AU - Badve, S.

AU - Denkert, C.

AU - Macgrogan, G.

AU - Penault-llorca, F.

AU - Viale, G.

AU - Cameron, D.

PY - 2015/5/27

Y1 - 2015/5/27

U2 - 10.1093/annonc/mdv161

DO - 10.1093/annonc/mdv161

M3 - Literature review

SN - 0923-7534

VL - 26

SP - 1280

EP - 1291

JO - Annals of Oncology

JF - Annals of Oncology

ER -